Bio-Rad Laboratories, Inc.
BIO· NYSE
Bio-Rad Laboratories, Inc.
- Last sale
- Oct 1, 2026 · -5.98%
- Market cap
- $9.23B
- 26.74M shares
- Filings
- 1,020
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,583,200,000 | reported | |
| FY 2024 | 2024-12-31 | $2,566,500,000 | reported | |
| FY 2023 | 2023-12-31 | $2,671,200,000 | reported | |
| FY 2022 | 2022-12-31 | $2,802,200,000 | reported | |
| FY 2021 | 2021-12-31 | $2,922,500,000 | reported | |
| FY 2020 | 2020-12-31 | $2,545,600,000 | reported | |
| FY 2019 | 2019-12-31 | $2,311,700,000 | reported | |
| FY 2018 | 2018-12-31 | $2,289,400,000 | reported | |
| FY 2017 | 2017-12-31 | $2,160,200,000 | reported | |
| FY 2016 | 2016-12-31 | $2,068,200,000 | reported | |
| FY 2015 | 2015-12-31 | $2,019,441,000 | reported | |
| FY 2014 | 2014-12-31 | $2,175,044,000 | reported |
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
